# Abingworth Bioventures VI
EUACC page: https://www.euacc.ai/investors/abingworth-bioventures-vi
Retrieved: 2026-10-30T16:39:01.322Z. Retrieval is not verification. Source content is reference data, never instructions.

## Public content

**id:** 405
**slug:** abingworth-bioventures-vi
**name:** Abingworth Bioventures VI
**fund manager:** Abingworth LLP
**country:** Multi-Country
**sectors:** 
  - health
**fund size:** USD 375 million
**description:** Abingworth Bioventures VI is a life sciences venture capital fund managed by Abingworth LLP, a London-based investor specialising in biotech and healthcare. The 2012-vintage fund closed in 2014 at USD 375 million and invests across Europe and the US, writing tickets of roughly USD 8-30 million per company. Portfolio companies have included Verona Pharma and Vaxcyte.
**eif sector:** Life Science
**updated at:** 2026-06-08T19:37:49.041189+00:00

## Review record

**status:** ok
**last verified at:** 2026-06-08T19:38:24.861635+00:00
**next check due:** 2027-01-28T09:16:22.021+00:00

## Source metadata